(R)-methyl pyrrolidine-3-carboxylate hydrochloride, 95.0%, 5g

5-Bromoimidazo[1,2-a]pyridine, 96.0%, 100g

4-Phenoxybenzonitrile, 98.0%, 25g

4,5-Difluoro-2-methylphenol, 95.0%, 5g

6-CHLORO-5-NITRO-1H-INDAZOLE, 95%, 250mg

2,3,4,5-Tetrahydrobenzo[f][1,4]thiazepine 1,1-dioxide, 97%, 100mg

3-(6-METHYL-PYRIDIN-2-YL)-PROPIONIC ACID, 95.0%, 500mg

6-Isocyano-2,3-dihydro-benzo[1,4]dioxine, 250mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 3000 ml, 190 mm, 1 Piece

METHYL 2-CYANO-3-FLUOROBENZOATE, 95%, 250mg

6-(4-((5-CHLORO-4-((4-CHLOROPHENYL)AMINO)PYRIMIDIN-2-YL)AMINO)-1H-PYRAZOL-1-YL)-N-HYDROXYHEXANAMIDE, 95%, 25mg

5,8-Dioxa-2-azaspiro[3.4]octane hydrochloride, 97%, 5g

7-Fluoroisoquinoline-1-carboxylic acid, 98%, 1g